---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-009686"
form_type: "8-K"
ticker: "HEPA"
cik: "0001583771"
company_name: "Hepion Pharmaceuticals, Inc."
filed_at: "2025-03-10T23:59:59+00:00"
generated_at: "2026-05-25T01:29:04.096597+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Hepion shareholders approve reverse stock split (1:10-1:50) at annual meeting

## Summary
- All four director nominees elected (Brancaccio, Block, Lbiati, Purcell) with majority 'For' votes.
- Ratification of Grassi & Co. as auditor for FY2024 approved: 2,974,800 For, 603,560 Against.
- Advisory say-on-pay approved: 1,419,035 For, 853,863 Against, 244,418 Abstentions.
- Issuance of shares upon Series A and B Warrants approved: 1,720,659 For, 793,847 Against.
- Reverse stock split amendment approved (2,685,475 For); board to set ratio (1:10-1:50) and timing.

## SEC filing metadata
- accession: 0001493152-25-009686
- form_type: 8-K
- ticker: HEPA
- cik: 0001583771
- company_name: Hepion Pharmaceuticals, Inc.
- filed_at: 2025-03-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583771/000149315225009686/0001493152-25-009686-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583771/000149315225009686/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-009686
- JSON: https://secwatch.observer/filing/0001493152-25-009686.json
- Plain text: https://secwatch.observer/filing/0001493152-25-009686.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.